Cognition Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Cognition Therapeutics Inc had 31.13M in cash and cash equivalents.

Cognition Therapeutics Inc reported 14.12M in total liabilities as of the latest reported quarter, including 13.92M in current liabilities and 195.00K in non-current liabilities.

As of the latest reported quarter, Cognition Therapeutics Inc's total assets were 48.39M, consisting of 47.99M in current assets and 399.00K in non-current assets.

Cognition Therapeutics Inc reported 34.27M in total shareholders' equity as of the latest reported quarter.